期刊文献+

去甲氧柔红霉素对耐药白血病细胞中Chk1磷酸化水平的影响 被引量:1

The study of effect of idarubicin on the expression of phosphorylated-Chk1 in drug-resistant acute leukemia cells
下载PDF
导出
摘要 目的:观察去甲氧柔红霉素(IDA)对耐药急性白血病细胞中细胞周期检测点激酶1(Chk1)磷酸化水平的影响,探讨Chk1信号通路在去甲氧柔红霉素抗瘤作用中的机制。方法:MTT法检测柔红霉素(DNR)和IDA的IC50,耐药白血病细胞分别与DNR和IDA的IC50共孵育,Western-blot检测细胞内Chk1磷酸化水平(P-Chk1)的表达,流式细胞术检测其细胞周期及细胞凋亡率。结果:DNR的IC50约为0.40μg/ml,IDA约为0.12μg/ml,以此浓度分别与AML细胞共孵育,6h后两组间S期、G2/M期细胞的百分率差异无显著性;24h后,DNR组S期和G2/M期细胞百分率分别为(3.56±1.17)%、(53.66±1.75)%,IDA组为(41.42±1.17)%、(28.45±3.72)%,差异有显著性;P-Chk1在DNR组为1.78±1.10,IDA组为0.56±1.25,两者比较差异有显著性;24h后,DNR组和IDA组的细胞凋亡率分别为(24.53±1.30)%、(66.47±2.61)%,IDA组明显高于DNR组,差异有显著性。结论:IDA可能通过下调P-Chk1水平延迟耐药白血病细胞的S期进程,从而增加自身的药物敏感性。 Objective:To explore the mechanisms of Chk1 signaling pathway involved in anti-leukemia ctivity of Idarubicin.Methods: IC50 of daunorubicin(DNR) and idarubicin(IDA) was detected by MTT.After treatment with daunorubicin and idarubicin respectively,Chk1 phosphorylation levels in acute leukemia cells was detected by Western-blot.The cell cycle distribution and cell apoptosis were detected by flow cytometry.Results: The 50% inhibition concentration(IC50) of DNR was about 0.40μg/ml,IDA was about 0.12μg/ml.Six hours after incubation with IC50 of anthracycline antibiotics individually,the proportion of the cell in S and G2/M phase between two group had no significant difference.24 hours after treatment,the proportion of the cell in G2/M phase for DNR was significantly higher than for IDA,the proportion of the cell in S phase for IDA was significantly higher than for DNR;the decreased Chk1 phosphorylation following DNA damage induced by IDA was observed in refractory cells(0.56±1.25),significantly lower than those induced by DNR(1.78±1.10);the cell apoptosis rates induced by IDA was(66.47±2.61)%,significantly higher than those induced by DNR(24.53±1.30)%.Conclusion: Idarubicin possibly delay progression of S phase in drug-resistant leukemia cells through downregulation of phosphorylated-Chk1 level,thus increasing its susceptibility.
出处 《陕西医学杂志》 CAS 2012年第3期269-271,275,共4页 Shaanxi Medical Journal
基金 湖北省宜昌市科技攻关计划项目(A2007302-13)
关键词 白血病 实验性/病理生理学 @Chk1磷酸化 @药物耐受性 @去甲氧柔红霉素 Leukemia Experimental/physiopathdogy @Phosphorylated-Chk1 @Drug tolerance @Idarubicin
  • 相关文献

参考文献10

  • 1Didier C,Cavelier C,Quaranta M,et al.G2/M check-point stringency is a key parameter in the sensitivity ofAML cells to genotoxic stress[J].Oncogene,2008,27(27):3811-20.
  • 2王海燕,张敏,邹萍,游泳,郭静明,唐晓琼,赵智刚,吴耀辉.活化Chk1引起的G_2/M期阻滞在调节K562/A02细胞耐药中的机制探讨[J].中国实验血液学杂志,2006,14(6):1105-1109. 被引量:4
  • 3王海燕,郭静明,刘红艳,叶松,刘斌,唐芳蓉.Chk1表达与急性髓系白血病细胞多药耐药的关系及临床意义[J].实用肿瘤杂志,2010,25(4):405-409. 被引量:1
  • 4Harper JW,Elledge SJ.The DNA damage response:tenyears after[J].Mol Cell,2007,14,28(5):739-45.
  • 5Yin MB,Guo B,Vanhoefer U,et al.Characterization ofprotein kinase Chk1essential for the cell cycle checkpointafter exposure of human head and neck carcinoma A253cells to a novel topoisomerase I inhibitor BNP1350[J].Mol Pharmacol,2000,57(3):453-59.
  • 6Sorensen CS,Syljuasen RG,Falck J,et al.Chk1regu-lates the S phase checkpoint by coupling the physiologicalturnover ionizing radiation-induced accelerated proteolysisof Cdc25A[J].Cancer cell,2003,3(3):247-58.
  • 7Scorah J,Mc Gowan CH.Claspin and Chk1regulate rep-lication fork stability by different mechanisms[J].CellCycle,2009,8(7):1036-43.
  • 8Conti C,SaccàB,Herrick J,et al.Replication fork ve-locities at adjacent replication origins are coordinatelymodified during DNA replication in human cells[J].MolBiol Cell,2007,18(8):3059-67.
  • 9Guo N,Faller DV,Vaziri C.Carcinogen-induced S-phasearrest is Chk1 mediated and caffeine sensitive[J].CellGrowth Differ,2002,13(2):77-86.
  • 10Walker M,Black EJ,Oehler V,et al.Chk1C-terminalregulatory phosphorylation mediates checkpoint activationby de-repression of Chk1catalytic activity[J].Oncogene,2009,28(24):2314-23.

二级参考文献27

  • 1栾凤君,杨纯正.一株人红白血病多药耐药细胞系(K562/A02)的建立及其耐药特性...[J].中华肿瘤杂志,1993,15(2):101-103. 被引量:68
  • 2王海燕,张敏,邹萍,游泳,郭静明,唐晓琼,赵智刚,吴耀辉.活化Chk1引起的G_2/M期阻滞在调节K562/A02细胞耐药中的机制探讨[J].中国实验血液学杂志,2006,14(6):1105-1109. 被引量:4
  • 3Kuntz K, O'Connell MJ. The G (2) DNA damage checkpoint: could this ancient regulator be the Achilles heel of cancer [ J ]. Cancer Biol Tiler, 2009,8 ( 15 ) : 1433 - 1439.
  • 4Bucher N, Britten CD. G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer [ J ]. Br J Cancer, 2008,98 ( 3 ) : 523 - 528.
  • 5Yin MB, Hapke G, Wu J, et al. Chkl signaling pathways that mediated G2/M checkpoint in relation to cellular resistance to the novel topoisomerase I poison BNP1350 [ J]. BBRC ,2002,295 (2) :435 - 444.
  • 6Didier C, Cavelier C, Quaranta M, et al. G2/M checkpoint stringency is a key parameter in the sensitivity of AML ceils to genotoxie stress [ J ]. Cell Cycle, 2008,27 ( 27 ) : 3811 - 3820.
  • 7Scorah J, McGowan CH. Claspin and Chk1 regulate replication fork stability by different mechanisms [ J ]. Cell Cycle ,2009,8 (7) : 1036 - 1043.
  • 8Conti C, Sacc B, Herrick J, et al. Replication fork velocities at adjacent replication origins are coordinately modified during DNA replication in human cells [ J]. Mol Biol Ce11,2007,18 ( 8 ) :3059 - 3067.
  • 9Huang M, Miao ZH, Zhu H, et al. Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins [ J]. Mol Cancer Ther, 2008,7(6) :1440 - 1449.
  • 10Tse AN, Sheikh TN, Alan H, et al. 90-kDa heat shock protein inhibition abrogates the topoisomerase I poison- induced G2/M checkpoint in p53-null tumor cells by depleting Chk1 and Weel [ J]. Mol Pharmacol,2009,75 (1) :124-133,.

共引文献3

同被引文献12

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部